Remifentanil induced hyperalgesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Optional thoracoscopic lobectomy; (2) Patients aged 20 to 65 years; (3) ASA class I~ II; (4) BMI18 ~ 30kg/m2; (5) General anesthesia was agreed, and sufentanil - based PCIA was accepted; (6) Can communicate with the doctor normally, cooperate with preoperative, intraoperative, postoperative evaluation and testing; (7) No serious cardiovascular disease and normal liver and kidney function; (8) Patients or their family members sign the informed consent form for this study.
Exclusion criteria
Exclusion criteria: (1) Allergic to nabulphine, ketorolac tromethamine or other drugs in this study; (2) The patient did not take analgesic and sedative drugs recently; (3) There is a serious mental nervous system disease; (4) The patient has a complex internal systemic disease; (5) A pregnant or lactating woman; (6) People considered unsuitable by researchers for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mechanical pain threshold; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative dosage of remifentanil;The number of times that PCA was effectively pressed within 24h after the patient was admitted to the ward;The time of the first effective pressure on PCA from the distance of extubation;Visual simulation scoring;Ramsay sedation score; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University